Despite explosive growth in the development of nano-drug delivery systems (NDDS)
targeting tumors in the last few decades, clinical translation rates are low owing to the lack of …

The in vitro simulation of organs resolves the accuracy, ethical, and cost challenges
accompanying in vivo experiments. Organoids and organs-on-chips have been developed …

Liver diseases are the primary reason for morbidity and mortality in the world. Owing to a
shortage of organ donors and postoperative immune rejection, patients routinely suffer from …

Supramolecular assemblies have been gaining attention in recent years in the field of drug
delivery because of their unique formulation possibilities and adaptive behavior. Their non …

The vasculature plays a critical role in cancer progression and metastasis, representing a
pivotal aspect in the creation of cancer models. In recent years, the emergence of organ-on …

The development of drug delivery systems with real-time cargo release monitoring
capabilities is imperative for optimizing nanomedicine performance. Herein, we report an …

The 3D bioprinting technique has made enormous progress in tissue engineering,
regenerative medicine and research into diseases such as cancer. Apart from individual …

Nanomedicines have been investigated for delivering drugs to tumors due to their ability to
accumulate in the tumor tissues. 2D in vitro cell culture has been used to investigate the …

Degradable polymeric micelles are promising drug delivery systems due to their
hydrophobic core and responsive design. When applying micellar nanocarriers for tumor …

Enzyme-responsive polymeric micelles hold great potential as drug delivery systems due to
the overexpression of disease-associated enzymes. To achieve selective and efficient …